Skip to main content
. 2021 Jan 6;17(2):319–332. doi: 10.1007/s12247-020-09525-2

Table 2.

Most relevant molecules where the TDD is applied for its administration

Protein, hormones, peptides Use in the treatment of Produced by
Estradiol/levonorgestrel Menopausal symptoms Climara Pro Bayer Healthcare Pharmaceuticals (Wayne, NJ)
Estradiol Menopausal symptoms Estraderm Novartis (East Hannover, NJ)
Ethinyl estradiol/norelgestromin Contraception Ortho Evra Ortho-McNeil Pharmaceutical (Raritan, NJ)
Fertility hormone Female infertility Vyteris/Ferring
Heat-labile enterotoxin of E. coli Travelers’ diarrhea Iomai
Human growth hormone Growth hormone deficiency TransPharma/Teva
Influenza vaccine Influenza prophylaxis Becton Dickinson/Sanofi-Pasteur
Insulin Diabetes mellitus Zealand Pharma/Altea
Parathyroid hormone (1–34) Osteoporosis Zosano Pharma, Inc.
Testosterone Female sexual dysfunction Acrux/VIVUS
Testosterone disorder Hypoactive sexual desire disorder Procter & Gamble/Watson
Testosterone Testosterone deficiency Testoderm Alza, Mountain View, CA